8162 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, how many (a) new cancer medicines and (b) new indications of existing cancer medicines are expected to be licensed between July 2015 and 31 March 2016.

George Freeman

8315 - Skin Cancer: Drugs (Answered)

Pauline Latham
To ask the Secretary of State for Health, what recent discussions he has had on the availability of nivolumab for melanoma patients through the Cancer Drugs Fund.

George Freeman

We have had no such discussions.

NHS England is responsible for the operational management of the Cancer Drugs Fund. It has taken a decision not to consider new drugs like nivolumab, at this stage, whilst consideration is given to new ways of working and to ensure that the Fund remains within budget.

8316 - Medical Treatments (Answered)

Pauline Latham
To ask the Secretary of State for Health, what steps he is taking to ensure access for NHS patients to innovative new medicines that have received marketing authorisation before their assessment from NICE.

George Freeman

In the absence of guidance from the National Institute for Health and Care Excellence, it is for commissioners to make decisions on whether to fund new medicines based on an assessment of the available evidence.

7762 - Postal Services: Compensation (Answered)

Alex Cunningham
To ask the Secretary of State for Business, Innovation and Skills, what discussions he has had with representatives of Royal Mail on the adequacy of the postal compensation scheme; and if he will make a statement.

George Freeman

We have had no such discussions. Royal Mail is required by regulation to ensure that it maintains fair and reasonable remedies and redress.

7529 - Medical Treatments (Answered)

Sir David Amess
To ask the Secretary of State for Health, what assessment he has made of variations in the length of time NHS trusts take to implement NICE guidance.

George Freeman

We have made no such assessment.

Commissioners are legally required to fund treatments recommended in the National Institute for Health and Care Excellence (NICE) technology appraisals or highly specialised technology evaluations, normally within three months of NICE’s guidance being published. Other guidance from NICE is not mandatory.

7541 - Medical Records (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, how many representations he has received from (a) individuals and (b) groups (i) in favour of and (ii) against care.data in the last six months.

George Freeman

7540 - Medical Records (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, when care.data will be rolled out nationally; and if he will make a statement.

George Freeman

7407 - Postal Services: Scotland (Answered)

Margaret Ferrier
To ask the Secretary of State for Business, Innovation and Skills, what assessment he has made of the effect of the privatisation of Royal Mail on (a) residential properties and (b) businesses in Scotland.

George Freeman

7709 - Medical Records (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, what assessments he has made of the deliverability of care.data during the pathfinder stage.

George Freeman

No information will be collected until Dame Fiona Caldicott, the National Patient Data Guardian, advises she is satisfied with the care.data pathfinder’s proposals and safeguards. A full evaluation of the pathfinder stage will take place before national rollout begins.

7710 - Medical Records (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, how many people have opted out of the care.data scheme in each of the pathfinder areas.

George Freeman

Pages